4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993. 329:977–986.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998. 352:837–853.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011. 34:Suppl 1. S62–S69.
7. Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 2006. 4th ed. Washington, D.C: Saunders;880–883.
8. Molinaro RJ. Targeting HbA1c: standardization and clinical laboratory measurement. MLO Med Lab Obs. 2008. 40:10–14. 16–19.
9. Song J, Kwon KC, Kim JH, Kim JW, Min WK, Lee SY, et al. Annual report on external quality assessment in metabolic disorders in Korea (2009). J Lab Med Qual Assur. 2010. 32:131–146.
10. Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. Document EP6-A. 2003. Wayne, PA: Clinical and Laboratory Standards Institute.
11. Clinical and Laboratory Standards Institute. Document EP5-A2. Evaluation of precision performance of quantitative measurement methods; approved guideline. 2004. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute.
12. Clinical and Laboratory Standards Institute. Document EP9-A2. Method comparison and bias estimation using patient samples; approved guideline. 2002. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute.
13. Little RR, Sacks DB. HbA1c: how do we measure it and what does it mean? Curr Opin Endocrinol Diabetes Obes. 2009. 16:113–118.
14. Caragher TE, Dohnal JC, Lomont ME. Cautionary note regarding HbA
1c methods predicting the clinical status of diabetic patients. Diabetes Care. 2000. 23:867–869.
Article
15. Kilpatrick ES. HbA1c measurement. J Clin Pathol. 2004. 57:344–345.
16. Hanas R, John G. International HbA
1c Consensus Committee. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care. 2010. 33:1903–1904.
Article
17. Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol. 2009. 3:446–451.
Article
18. Jones TG, Warber KD, Roberts BD. Analysis of hemoglobin A1c from dried blood spot samples with the Tina-quantR II immunoturbidimetric method. J Diabetes Sci Technol. 2010. 4:244–249.
Article
19. Lee ST, Kim MS, Choi DY, Kim SK, Ki CS. Incidence of variant hemoglobin (Hb) and increased fetal Hb concentrations and their effect on HbA
1c measurement in a Korean population. Clin Chem. 2006. 52:1445–1446.
Article